Semmax Financial Advisors Inc. Acurx Pharmaceuticals, Inc. Transaction History
Semmax Financial Advisors Inc.
- $351 Million
- Q1 2025
A detailed history of Semmax Financial Advisors Inc. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 5,640 shares of ACXP stock, worth $4,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,640
Previous 7,179
21.44%
Holding current value
$4,624
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ACXP
# of Institutions
27Shares Held
3.49MCall Options Held
100Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ2.04MShares$1.68 Million6.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA529KShares$434,0660.0% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$300,5920.08% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$140,6190.0% of portfolio
-
Morgan Stanley New York, NY106KShares$87,0840.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $9.48M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...